![](/_default_upload_bucket/827/image-thumb__827__mastheadFocalsmall/Tests.d4a3abf5.png)
![](/_default_upload_bucket/827/image-thumb__827__mastheadFocalsmall/Tests.d4a3abf5.png)
Tests
Castle Biosciences Diagnostic & Prognostic Tests Overview
Our portfolio of innovative tests target unmet clinical needs along the patient care continuum. We are improving health through innovative tests that guide patient care.
![]( /_default_upload_bucket/1268/image-thumb__1268__text-image-alternate/Prognostics.f7df4174.png)
Prognostic
Our prognostic tests go beyond traditional diagnostic approaches, providing physicians with a comprehensive understanding of disease aggressiveness, recurrence risk and treatment response.
![]( /_default_upload_bucket/1267/image-thumb__1267__text-image-alternate/Diagnostics.9ab4226e.png)
Diagnostic
Our diagnostic test provides increased clarity for difficult-to-diagnose melanocytic lesions that informs important patient management decisions.
![]( /_default_upload_bucket/1269/image-thumb__1269__text-image-alternate/Pharmacogenomic%20%28PGx%29.95947223.png)
Pharmacogenomics (PGx)
Our pharmacogenomic (PGx) test utilizes precision medicine, enabling tailored treatment strategies based on an individual's genetic profile and lifestyle factors.